Monitoring of human cytomegalovirus-specific CD4+ and CD8 + T-cell immunity in patients receiving solid organ transplantation

G. Gerna, D. Lilleri, C. Fornara, G. Comolli, L. Lozza, C. Campana, C. Pellegrini, F. Meloni, T. Rampino

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Absolute and human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T-cell counts were monitored in 38 solid organ (20 heart, 9 lung and 9 kidney) transplant recipients during the first year after transplantation by a novel assay based on T-cell stimulation with HCMV-infected autologous dendritic cells. According to the pattern of T-cell restoration occurring either within the first month after transplantation or later, patients were classified as either early (n = 21) or late responders (n = 17). HCMV-specific CD4 + and CD8+ T-cell counts were consistently lower in late compared to early responders from baseline through 6 months after transplantation. In addition, in late responders, while HCMV infection preceded immune restoration, HCMV-specific CD4+ restoration was significantly delayed with respect to CD8+ T-cell restoration. The number of HCMV-specific CD4+ and CD8+ T-cells detected prior to transplantation significantly correlated with time to T-cell immunity restoration, in that higher HCMV-specific T-cell counts predicted earlier immune restoration. Clinically, the great majority of early responders (18/21, 85.7%) underwent self-resolving HCMV infections (p = 0.004), whereas the great majority of late responders (13/17, 76.5%) were affected by HCMV infections requiring antiviral treatment (p =

Original languageEnglish
Pages (from-to)2356-2364
Number of pages9
JournalAmerican Journal of Transplantation
Volume6
Issue number10
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Organ Transplantation
Cytomegalovirus
Immunity
T-Lymphocytes
Cytomegalovirus Infections
Transplantation
Cell Count
Dendritic Cells
Antiviral Agents
Kidney
Lung

Keywords

  • HCMV-specific CD4 T cells
  • HCMV-specific CD8 T cells
  • Human cytomegalovirus
  • Monitoring of T-cell immunity
  • T-cell immunity solid organ transplantation

ASJC Scopus subject areas

  • Immunology

Cite this

@article{6324e6b2329742a5acb4d8ce7fb4bc7a,
title = "Monitoring of human cytomegalovirus-specific CD4+ and CD8 + T-cell immunity in patients receiving solid organ transplantation",
abstract = "Absolute and human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T-cell counts were monitored in 38 solid organ (20 heart, 9 lung and 9 kidney) transplant recipients during the first year after transplantation by a novel assay based on T-cell stimulation with HCMV-infected autologous dendritic cells. According to the pattern of T-cell restoration occurring either within the first month after transplantation or later, patients were classified as either early (n = 21) or late responders (n = 17). HCMV-specific CD4 + and CD8+ T-cell counts were consistently lower in late compared to early responders from baseline through 6 months after transplantation. In addition, in late responders, while HCMV infection preceded immune restoration, HCMV-specific CD4+ restoration was significantly delayed with respect to CD8+ T-cell restoration. The number of HCMV-specific CD4+ and CD8+ T-cells detected prior to transplantation significantly correlated with time to T-cell immunity restoration, in that higher HCMV-specific T-cell counts predicted earlier immune restoration. Clinically, the great majority of early responders (18/21, 85.7{\%}) underwent self-resolving HCMV infections (p = 0.004), whereas the great majority of late responders (13/17, 76.5{\%}) were affected by HCMV infections requiring antiviral treatment (p =",
keywords = "HCMV-specific CD4 T cells, HCMV-specific CD8 T cells, Human cytomegalovirus, Monitoring of T-cell immunity, T-cell immunity solid organ transplantation",
author = "G. Gerna and D. Lilleri and C. Fornara and G. Comolli and L. Lozza and C. Campana and C. Pellegrini and F. Meloni and T. Rampino",
year = "2006",
month = "10",
doi = "10.1111/j.1600-6143.2006.01488.x",
language = "English",
volume = "6",
pages = "2356--2364",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Monitoring of human cytomegalovirus-specific CD4+ and CD8 + T-cell immunity in patients receiving solid organ transplantation

AU - Gerna, G.

AU - Lilleri, D.

AU - Fornara, C.

AU - Comolli, G.

AU - Lozza, L.

AU - Campana, C.

AU - Pellegrini, C.

AU - Meloni, F.

AU - Rampino, T.

PY - 2006/10

Y1 - 2006/10

N2 - Absolute and human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T-cell counts were monitored in 38 solid organ (20 heart, 9 lung and 9 kidney) transplant recipients during the first year after transplantation by a novel assay based on T-cell stimulation with HCMV-infected autologous dendritic cells. According to the pattern of T-cell restoration occurring either within the first month after transplantation or later, patients were classified as either early (n = 21) or late responders (n = 17). HCMV-specific CD4 + and CD8+ T-cell counts were consistently lower in late compared to early responders from baseline through 6 months after transplantation. In addition, in late responders, while HCMV infection preceded immune restoration, HCMV-specific CD4+ restoration was significantly delayed with respect to CD8+ T-cell restoration. The number of HCMV-specific CD4+ and CD8+ T-cells detected prior to transplantation significantly correlated with time to T-cell immunity restoration, in that higher HCMV-specific T-cell counts predicted earlier immune restoration. Clinically, the great majority of early responders (18/21, 85.7%) underwent self-resolving HCMV infections (p = 0.004), whereas the great majority of late responders (13/17, 76.5%) were affected by HCMV infections requiring antiviral treatment (p =

AB - Absolute and human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T-cell counts were monitored in 38 solid organ (20 heart, 9 lung and 9 kidney) transplant recipients during the first year after transplantation by a novel assay based on T-cell stimulation with HCMV-infected autologous dendritic cells. According to the pattern of T-cell restoration occurring either within the first month after transplantation or later, patients were classified as either early (n = 21) or late responders (n = 17). HCMV-specific CD4 + and CD8+ T-cell counts were consistently lower in late compared to early responders from baseline through 6 months after transplantation. In addition, in late responders, while HCMV infection preceded immune restoration, HCMV-specific CD4+ restoration was significantly delayed with respect to CD8+ T-cell restoration. The number of HCMV-specific CD4+ and CD8+ T-cells detected prior to transplantation significantly correlated with time to T-cell immunity restoration, in that higher HCMV-specific T-cell counts predicted earlier immune restoration. Clinically, the great majority of early responders (18/21, 85.7%) underwent self-resolving HCMV infections (p = 0.004), whereas the great majority of late responders (13/17, 76.5%) were affected by HCMV infections requiring antiviral treatment (p =

KW - HCMV-specific CD4 T cells

KW - HCMV-specific CD8 T cells

KW - Human cytomegalovirus

KW - Monitoring of T-cell immunity

KW - T-cell immunity solid organ transplantation

UR - http://www.scopus.com/inward/record.url?scp=33748494938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748494938&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2006.01488.x

DO - 10.1111/j.1600-6143.2006.01488.x

M3 - Article

VL - 6

SP - 2356

EP - 2364

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 10

ER -